Tumor-infiltrating lymphocytes in melanoma: diagnostic and prognostic implications from biopsy to circulation

Melanoma is a highly aggressive skin cancer that arises from melanocytes and presents considerable clinical challenges due to its strong metastatic capacity and ability to evade the immune system. Tumor-infiltrating lymphocytes (TILs) reflect the host's immune activity within the tumor microenv...

Full description

Bibliographic Details
Published in:	The Journal of Liquid Biopsy
Main Author:	Hussain Noorwali
Format:	Article
Language:	English
Published:	Elsevier 2025-09-01
Subjects:	Melanoma Tumor-infiltrating lymphocytes Immune profiling Peripheral T cells Prognostic biomarkers
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950195425000244

Similar Items

Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastasesResearch in context
by: Eftychia Chatziioannou, et al.
Published: (2023-07-01)

FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma
by: Zhenguo Cai, et al.
Published: (2023-11-01)

Role of tumor-infiltrating lymphocytes in melanoma prognosis and treatment strategies: A systematic review and meta-analysis
by: Mattia Garutti, et al.
Published: (2024-06-01)

Tumoral inflammatory infiltrate does not predict metastases in thin primary cutaneous melanomas
by: Mariele Bevilaqua, et al.
Published: (2023-11-01)

Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications
by: Meshack Bida, et al.
Published: (2024-12-01)

Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma
by: I.A.J. van Duin, et al.
Published: (2024-12-01)

SUBPOPULATION COMPOSITION OF PERIPHERAL BLOOD LYMPHOCYTES IN UVEAL MELANOMA
by: Svetlana Vladimirovna Saakyan, et al.
Published: (2019-10-01)

Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study
by: Sümeyre Seda Ertekin, et al.
Published: (2024-04-01)

LYMPHOCYTE PHENOTYPE IN PATIENTS WITH SKIN MELANOMA AFTER IMMUNOTHERAPY OF ACTIVATED LYMPHOCYTES
by: E. V. Abakushina, et al.
Published: (2015-01-01)

Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma
by: D. König, et al.
Published: (2024-12-01)

The impact of MITF expression on tumor-infiltrating lymphocytes in melanoma: Insights into immune microenvironment dynamics
by: Damir Vučinić, et al.
Published: (2025-02-01)

Prognostic significance of peripheral and tumor-infiltrating lymphocytes in newly diagnosed stage III/IV non-small-cell lung cancer
by: Fenge Li, et al.
Published: (2024-05-01)

Molecular and immune landscape of melanoma: a risk stratification model for precision oncology
by: Miao Sun, et al.
Published: (2025-05-01)

Artificial intelligence for tumor-infiltrating lymphocytes (TILs) assessment in breast cancer: a narrative review
by: Nurkhairul Bariyah Baharun, et al.
Published: (2025-10-01)

ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma
by: Shougang Liu, et al.
Published: (2021-03-01)

Density of high endothelial venules and PDL-1 expression: relationship with tumor-infiltrating lymphocytes in primary cutaneous melanomas
by: JOSIANE B. STOLFO, et al.
Published: (2024-03-01)

Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma
by: Yanhua Cheng, et al.
Published: (2022-12-01)

Liquid biopsy for diagnostic and prognostic evaluation of melanoma
by: Nicholas Slusher, et al.
Published: (2024-08-01)

Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma
by: T.J. Monberg, et al.
Published: (2024-12-01)

Single-cell RNA sequencing reveals key molecular drivers and immune landscape in uveal melanoma: implications for targeted therapy and prognostic modeling
by: Zeyu Song, et al.
Published: (2024-11-01)

Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas
by: Nicole L. Edmonds, et al.
Published: (2023-12-01)

Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis
by: Qin Yan, et al.
Published: (2024-09-01)

An update on methods for detection of prognostic and predictive biomarkers in melanoma
by: Oluwaseyi Adeuyan, et al.
Published: (2023-10-01)

Prognostic Value of Deep Learning‐Extracted Tumor‐Infiltrating Lymphocytes in Esophageal Cancer: A Multicenter Retrospective Cohort Study
by: Peishen Li, et al.
Published: (2025-07-01)

The Impact of Nutritional Status and Tumor-Infiltrating Lymphocytes (CD4+ and CD8+) on Chemotherapy Response in Colorectal Cancer Patients
by: Lukman K, et al.
Published: (2025-01-01)

Histopathological biomarkers in squamous cell carcinoma of the vulva: the prognostic relevance of tumor-infiltrating lymphocytes (TILs)—a retrospective study of 157 cases
by: Gilbert Georg Klamminger, et al.
Published: (2025-04-01)

Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns
by: Agata Mlynska, et al.
Published: (2024-01-01)

Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma
by: Jung-Soo Pyo, et al.
Published: (2021-11-01)

Tumor-infiltrating CD8+ lymphocytes effect on clinical outcome of muco-cutaneous melanoma
by: Mahtab Rahbar, et al.
Published: (2015-01-01)

Identification and validation of a KRAS-macrophage-associated gene signature as prognostic biomarkers and potential therapeutic targets in melanoma
by: Beichen Cai, et al.
Published: (2025-06-01)

Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study
by: Danielle R. Davari, et al.
Published: (2021-11-01)

Global pannexin 1 deletion increases tumor‐infiltrating lymphocytes in the BRAF/Pten mouse melanoma model
by: Rafael E. Sanchez‐Pupo, et al.
Published: (2024-04-01)

Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer
by: Canxuan Li, et al.
Published: (2023-03-01)

Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma
by: Anna Tosi, et al.
Published: (2021-12-01)

Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients
by: Francesco De Logu, et al.
Published: (2021-02-01)

Is the neutrophil-to-lymphocyte ratio a useful prognostic indicator in melanoma patients?
by: Joshua T Cohen, et al.
Published: (2020-09-01)

Development of a prognostic model for breast cancer patients based on intratumoral tumor-infiltrating lymphocytes using machine learning algorithms
by: Xinyi Wu, et al.
Published: (2025-05-01)

Comparison of expression of molecular markers of peripheral blood lymphocyte activation in patients with small uveal melanoma and healthy controls
by: S.I. Poliakova, et al.
Published: (2016-12-01)

The clinical pathological characteristics of malignant melanoma in nasal cavity and paranasal sinuses and its correlation with subsets of tumor infiltrating lymphocytes
by: WANG Lining, LIU Honggang
Published: (2025-04-01)

CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study
by: Chunhong Li, et al.
Published: (2022-09-01)